Coltsfoot (Tussilago farfara) – Nature Makes Well

Nomenclature & Taxonomic Classification

Physical Description: * Growth Habit: Low-growing perennial herb rising 10–25 cm high from a creeping rhizome.
- Morphology: The bright yellow daisy-like flowers appear in very early spring before the leaves emerge (hence “son-before-the-father”). The leaves emerge later, basal, large, cordate, with angular teeth, resembling a colt’s hoof, dark green above and white-felted with dense woolly hairs beneath.
Habitat & Cultivation: Native to Europe, North and Central Asia, and North Africa; naturalized in North America. Prefers moist, alkaline, clay-heavy soils, stream banks, damp ditches, and railway embankments.
Sustainability Status: Secure and abundant wildweed.

Western Tissue States: Corrects Atrophy/Dryness (rich demulcent that coats parched respiratory linings) and Constriction/Tension (relaxes irritable spastic coughing fits).
Traditional Vector:
- Ayurveda: Rasa (Taste): Tikta (Bitter), Madhura (Sweet), Kashaya (Astringent) | Virya (Energy): Neutral to Slightly Cooling | Vipaka (Post-Digestive Effect): Madhura (Sweet) | Dosha Modulation: Pacifies Pitta and Kapha; balances Vata.
- Traditional Chinese Medicine: Temperature: Warm (Flowers) / Neutral (Leaves) | Taste: Sweet, Bitter | Organ Meridians Entered: Lung
Historical Folk Use: Its generic name Tussilago literally translates to “cough dispenser.” Used for over two millennia as a core smoking herb or herbal tea to break acute asthma attacks, whooping cough, and dry pulmonary irritation.

Primary Phytochemicals: Mucilage (up to 7–10% polysaccharides); flavonoids (rutin, hyperoside); tannins; volatile oils; trace hepatotoxic unsaturated pyrrolizidine alkaloids (PAs, specifically senkirkine and tussilagine).
Mechanism of Action: > The abundant water-soluble polysaccharides form a direct demulcent layer over the upper respiratory mucous membranes, masking local sensory cough receptors and cooling tissue irritation. Concurrently, the flavonoid fraction exerts an anti-spasmodic action on the bronchial smooth muscle matrix, relaxing constriction to dilate airways and transform a dry, unproductive cough into a productive one.

Primary Indications: Acute or chronic dry bronchitis, hacking unproductive coughs, laryngitis, tracheitis, emphysema support, and throat irritation.
Secondary Indications: Mild asthma flares and localized mouth or throat ulcerations (as a gargle).
Modern Clinical Evidence: Pharmacological studies confirm that Coltsfoot mucilage displays significant demulcent and anti-tussive efficacy. Due to the presence of PAs, its modern internal status is highly regulated, necessitating brief clinical windows or the use of PA-free cultivated configurations.

Optimal Menstruum & Extraction Guidelines: Best extracted as a brief hot water infusion to capture maximum soothing mucilage while minimizing the extraction of lipophilic alkaloids. Limit use to short-term acute protocols.

Delivery Method	Standard Clinical Dosage	Frequency / Administration
Infusion	1–2 grams dried leaf per 250 mL water	Steeped covered 10 mins; taken 2–3x daily; MAXIMUM 4–6 WEEKS USE PER YEAR
Tincture (1:5, 40% EtOH)	NOT RECOMMENDED unless certified PA-free	N/A
Traditional Herbal Smoke	Small pinch of dried leaf burnt	Inhaled briefly to acutely break an asthmatic spasm

Contraindications: Absolutely contraindicated during pregnancy, lactation, in children, and in individuals with active or historical liver disease.
Side Effects & Toxicity Thresholds: Coltsfoot leaves contain unsaturated pyrrolizidine alkaloids (PAs), which are cumulative hepatotoxins. Long-term high-dose internal use can induce hepatic veno-occlusive disease (HVOD), irreversible liver cirrhosis, and carcinogenicity. Modern European guidelines mandate that daily exposure must not exceed 1 microgram of PAs; restrict usage to brief, acute formulas.
Pharmaceutical Cross-Interactions: * Enzyme Alterations: PAs can modify specific cytochrome enzyme degradation loops.
- Additive Pathways: Potentiates the actions of other hepatotoxic agents.